Introduction
============

Stroke affects 15 million people worldwide annually, among which five million die and another five million are left permanently disabled, making it a major cause of morbidity and mortality ([@R4]; [@R14]). In addition, stroke survivors experience impaired motor function of the upper limb, which commonly leads to functional limitations and disabilities and affects their daily life ([@R1]). Various symptoms of central nervous system damage after stroke may occur, in which muscle spasticity, caused by the upper motor neuron lesion, is a common complication and the most common clinical challenge ([@R7]).

Spasticity, according to [@R15], is a typical component of upper motor neuron syndrome characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks resulting in hyperexcitability of the stretch reflex. Globally, 12 million people have spasticity of the upper or lower limb ([@R23]; [@R6]). It occurs in 19 and 39% at 3 and 12 months after stroke, respectively ([@R25]). Because of long-term complications such as chronic pain, joints deformities, heterotrophic ossifications, bones demineralization, or muscles contractures with their atrophy, spasticity seriously affects important functions of daily living, causing discomfort, stiffness, and limitations in physical activities and daily life, and leads to increased medical bills ([@R8]; [@R22]). Therefore, control and treatment of spasticity in the rehabilitation of upper extremity motor function after stroke have become increasingly important.

Mirror therapy (MT) is a simple, inexpensive, and patient-oriented method ([@R2]). Since [@R19] first introduced the use of MT, it has been shown to reduce phantom sensations and pain caused by amputation and improve range of motion, speed, and accuracy of arm movement and function ([@R26]). In addition, it has been suggested as a promising rehabilitation approach for recovery of motor function of the upper limb in poststroke patients.

Meanwhile, recent studies have shown that extracorporeal shock wave therapy (ESWT) is a new, reversible, and noninvasive method for the treatment of spasticity after stroke ([@R18]; [@R21]; [@R16]). These studies applied ESWT to treat upper or lower limb spasticity and suggested that ESWT is effective in treating spasticity and improving some parameters without causing muscle weakness or unpleasant effects in patients with stroke, cerebral palsy, and multiple sclerosis.

MT and ESWT are both promising and effective methods for motor recovery of upper limb spasticity in poststroke patients. We hypothesized that MT in combination with ESWT could lead to greater improvement of spasticity after stroke. Therefore, in the present study, we combined MT and ESWT as a new therapy (ETMS+MT) to verify our hypothesis and investigate its feasibility and the possible effects on upper limb spasticity in poststroke patients.

Patients and methods
====================

Study design
------------

A randomized controlled trial design was used in this present study, and the patients were divided into four groups (group A, *n*=30; group B, *n*=30, group C, *n*=30; group D, *n*=30) by random allocation software. Patients in group D received conventional rehabilitation therapy for 30 min per day, five times a week, for 4 weeks. The conventional program consisted of exercise therapy, occupational therapy, and neurodevelopmental facilitation techniques. In addition to the conventional rehabilitation program, patients in groups A, B, and C added MT, ESWT, and MT+ESWT training, respectively, for 20 min per day, five times a week, for 4 weeks (Fig. [1](#F1){ref-type="fig"}). The procedures were administered by an occupational therapist who was not involved in the assessment of the patients.

![Flow diagram of the study design. ESWT, extracorporeal shock wave therapy; MT, mirror therapy.](mrr-42-31-g001){#F1}

Participants
------------

One hundred and thirty-seven poststroke inpatients were recruited for this study from the Department of Oncology, the Second Affiliated Hospital of Wenzhou Medical University, China, from January 2015 to December 2017. Participants with disease duration more than 6 months, with modified Ashworth scale (MAS) score more than 1 and less than 4 for the upper limb flexor tension, with no cognitive problems, and who can understand and follow simple verbal instructions were recruited. One hundred and twenty participants were eligible for the study. The study was approved by the Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University. All participants provided informed consent according to the Declaration of Helsinki before study enrollment.

Interventions
-------------

Patients in group A sat on a stool in front of a table with a 30-cm^2^ mirror. The affected hand was placed behind the mirror so that it could not be seen, and the unaffected hand was placed in the reflecting side of the mirror. Patients were asked to move their wrist while simultaneously observing the reflection of the unaffected hand. In group B, 2000 shots with a pressure of 2.0--3.0 bar and frequency of 8 Hz were used diffusely for the intrinsic muscles and flexor digitorum tendon of the hand by an ultrasound pointer guide (Terason, t3000; Teratech, Burlington, Massachusetts, USA). The procedure was within tolerable pain limits. Patients in group C performed MT and received ESWT in parallel on the wrist extensor of the affected side.

Outcome measures
----------------

All patients in the four groups were examined by the same outcome assessors, who were unaware of treatment procedure. Evaluations were performed before the interventions and 1, 3, 6, and 12 months after the last interventions.

Fugl--Meyer assessment of upper extremity motor recovery
--------------------------------------------------------

The Fugl--Meyer assessment (FMA), which has impressive test--retest and inter-rater reliability and construct validity, quantitatively measures motor recovery after stroke ([@R20]; [@R11]). The score for the motor skill assessment included 66 and 34 points for the affected upper and lower limbs, respectively. The motor skills of the upper limb were assessed in our study. A three-point ordinal scale (0, cannot perform; 1, perform partially; 2, perform completely) was adopted.

Modified Ashworth scale for spasticity assessment
-------------------------------------------------

Spasticity is clinically evaluated by the MAS, which is a six-point rating scale with scores ranging from 0 to 4, where 0 indicates no increase in muscle tone and four indicates that the affected limb is rigid during flexion or extension ([@R12]). The measurement, which has good inter-rater and intra-rater reliability, is performed by calculating the degree and point of resistance when a muscle is manually stretched.

Statistical analysis
--------------------

Data in this study were analyzed by SPSS 18.0 (IBM, Armonk, New York, USA). Independent *t*-test, *χ*^2^-test, and Mann--Whitney *U*-test were used as homogeneity tests for demographic and medical characteristics. Wilcoxon's matched-pairs signed ranks test was used to compare results obtained before and after intervention. One-way analysis of variance followed by Bonferroni post-hoc tests was used to compare the differences among the four groups. Statistical significance was accepted for *P* values less than 0.05 in all tests.

Results
=======

Recruitment and sample size
---------------------------

Patients were recruited between January 2016 and December 2017. In total, 120 patients agreed to participate in the study and were assigned to group A (*n*=30), group B (*n*=30), group C (*n*=30) or group D (*n*=30) (Fig. [1](#F1){ref-type="fig"}). All the participants completed the full protocol. The 12-month follow-up questionnaire was completed by all of the patients. No adverse effects or complications were observed after the interventions in any of the four groups. There were no significant differences in the demographic and baseline clinical characteristics of the participants in any of the four groups (Table [1](#T1){ref-type="table"}).

###### 

General characteristics of participants
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Changes in the Fugl--Meyer assessment and modified Ashworth scale of the four group
-----------------------------------------------------------------------------------

Table [2](#T2){ref-type="table"} presents the comparisons of upper extremity motor performance and spasticity before and after treatment in the four groups. The FMA scores of group C were significantly greater than that of group D at all observed time points after treatment and were significantly greater than groups A and B especially at 6 and 12 months, but no significant differences were observed between groups A and B until the 12 months. Meanwhile, the post-treatment MAS scores were statistically lower in group C than in group D at all observed time points after treatment and were significantly greater than in groups A and B especially at 6 and 12 months. Moreover, the differences in MAS scores between groups A and B reached significance at 6 months.
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Changes in the Fugl--Meyer assessment and modified Ashworth scale
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Discussion
==========

Our present study results showed that MT combined with ESWT produced greater improvement in upper extremity motor performance and significant reduction in spasticity, and the effects lasted at least 12 months compared with those of MT alone or ESWT alone. This is the first randomized, single-blind study to investigate the feasibility and possible effects of MT combined with ESWT for the treatment of upper limb spasticity in poststroke patients.

Since [@R3] first reported that MT can be possibly used in rehabilitating the motor function of the affected arms of poststroke patients, more studies found that MT may improve the motor function of the upper extremity in patients with stroke ([@R17]; [@R5]; [@R13]). Moreover, the activation of the primary motor cortex (M1) or mirror neurons has been proposed as the possible mechanism of MT ([@R9]). However, previous studies reported that MT has invalid effect on upper limb spasticity after stroke ([@R24]). Various clinical experiment studies have demonstrated that ESWT could be used efficiently in the treatment of musculoskeletal disorders such as chronic tendinopathies, calcific tendinitis of the shoulder, lateral epicondylitis, and plantar fasciitis ([@R10]). In addition, recent studies have applied ESWT to patients with stroke with upper or lower limb spasticity and showed that ESWT is effective in treating spasticity and improving some parameters ([@R7]). Therefore, in our present study, we hypothesized that MT, which induces motor performance recovery, combined with ESWT could lead to greater improvement of spasticity after stroke. Our results showed that compared with the MT or ESWT group, the MT+ESWT group had significantly improved upper extremity motor performance and reduced spasticity, and the effects lasted 12 months based on FMA and MAS scores, whereas the MT+ESWT groups achieved improvement until 6 and 12 months. More importantly, these findings have not been reported until now.

This study has a few limitations. First, the small number of participants may affect the generalizability of the study findings. Second, we used FMA and MAS to measure motor improvement, but did not evaluate the Brunnstrom stages of motor recovery. Thus, further studies, are needed to evaluate the long-term therapeutic benefits of MT-ESWT on the motor recovery of upper limb spasticity after stroke.

Conclusion
----------

The use of MT+ESWT might be beneficial in the recovery of upper limb spasticity in poststroke patients and could be a promising and effective method for clinical therapy.

Zhejiang Province, medical and health science and technology projects (no. 2018PY033).

Conflicts of interest
=====================

There are no conflicts of interest.
